Camilla Salvagno
Overview
Explore the profile of Camilla Salvagno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
368
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hwang S, Awasthi D, Jeong J, Sandoval T, Chae C, Ramos Y, et al.
Nature
. 2024 Oct;
635(8040):1010-1018.
PMID: 39443795
Mounting effective immunity against pathogens and tumours relies on the successful metabolic programming of T cells by extracellular fatty acids. Fatty-acid-binding protein 5 (FABP5) has a key role in this...
2.
Emmanuelli A, Salvagno C, Hwang S, Awasthi D, Sandoval T, Chae C, et al.
Oncoimmunology
. 2024 Oct;
13(1):2411070.
PMID: 39364290
High-grade serious ovarian cancer (HGSOC) is an aggressive malignancy that remains refractory to current immunotherapies. While advanced stage disease has been extensively studied, the cellular and molecular mechanisms that promote...
3.
Emmanuelli A, Salvagno C, Min-Hwang S, Awasthi D, Sandoval T, Chae C, et al.
bioRxiv
. 2024 Aug;
PMID: 39211073
High-grade serous ovarian cancer (HGSOC) is an aggressive malignancy that remains refractory to current immunotherapies. While advanced stage disease has been extensively studied, the cellular and molecular mechanisms that promote...
4.
Sandoval T, Salvagno C, Chae C, Awasthi D, Giovanelli P, Marin Falco M, et al.
Cancer Discov
. 2024 Jul;
14(10):1901-1921.
PMID: 39073085
Iron accumulation in tumors contributes to disease progression and chemoresistance. Although targeting this process can influence various hallmarks of cancer, the immunomodulatory effects of iron chelation in the tumor microenvironment...
5.
Awasthi D, Chopra S, Cho B, Emmanuelli A, Sandoval T, Hwang S, et al.
J Clin Invest
. 2023 Jul;
133(17).
PMID: 37432737
Recognition of pathogen-associated molecular patterns can trigger the inositol-requiring enzyme 1 α (IRE1α) arm of the endoplasmic reticulum (ER) stress response in innate immune cells. This process maintains ER homeostasis...
6.
Duits D, Salvagno C, Raeven E, Vrijland K, Stip M, Hau C, et al.
Cells
. 2022 Aug;
11(15).
PMID: 35954190
Neutrophils are not only crucial immune cells for the neutralization of pathogens during infections, but they are also key players in tissue repair and cancer. Several methods are available to...
7.
Salvagno C, Mandula J, Rodriguez P, Cubillos-Ruiz J
Trends Cancer
. 2022 Jul;
8(11):930-943.
PMID: 35817701
The tumor microenvironment (TME) provokes endoplasmic reticulum (ER) stress in malignant cells and infiltrating immune populations. Sensing and responding to ER stress is coordinated by the unfolded protein response (UPR),...
8.
Chae C, Sandoval T, Hwang S, Park E, Giovanelli P, Awasthi D, et al.
Cancer Discov
. 2022 May;
12(8):1904-1921.
PMID: 35552618
Significance: This study uncovers that ATX-LPA is a central immunosuppressive pathway in the ovarian tumor microenvironment. Ablating this axis sensitizes ovarian cancer hosts to various immunotherapies by unleashing protective type...
9.
Kos K, Salvagno C, Wellenstein M, Aslam M, Meijer D, Hau C, et al.
Oncoimmunology
. 2022 Apr;
11(1):2063225.
PMID: 35481289
While regulatory T cells (T) and macrophages have been recognized as key orchestrators of cancer-associated immunosuppression, their cellular crosstalk within tumors has been poorly characterized. Here, using spontaneous models for...
10.
Paffenholz S, Salvagno C, Ho Y, Limjoco M, Baslan T, Tian S, et al.
Proc Natl Acad Sci U S A
. 2022 Jan;
119(5).
PMID: 35082152
High-grade serous ovarian carcinoma (HGSOC) is a cancer with dismal prognosis due to the limited effectiveness of existing chemo- and immunotherapies. To elucidate mechanisms mediating sensitivity or resistance to these...